Similar articles for PMID: 32102852

Year	Number of Results
1981	1
1986	2
1987	1
1994	1
1998	1
2000	3
2001	1
2002	1
2003	3
2004	3
2005	3
2006	3
2007	4
2008	4
2009	6
2010	6
2011	2
2012	3
2013	4
2014	7
2015	5
2016	7
2017	5
2018	8
2019	9
2020	11
2021	3
2022	14
2023	6
2024	0

1

Validation of an Epstein-Barr Virus Antibody Risk Stratification Signature for Nasopharyngeal Carcinoma by Use of Multiplex Serology.

Simon J, Liu Z, Brenner N, Yu KJ, Hsu WL, Wang CP, Chien YC, Coghill AE, Chen CJ, Butt J, Proietti C, Doolan DL, Hildesheim A, Waterboer T. Simon J, et al. J Clin Microbiol. 2020 Apr 23;58(5):e00077-20. doi: 10.1128/JCM.00077-20. Print 2020 Apr 23. J Clin Microbiol. 2020. PMID: 32102852 Free PMC article.

2

Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosis.

Simon J, Brenner N, Reich S, Langseth H, Hansen BT, Ursin G, Ferreiro-Iglesias A, Brennan P, Kreimer AR, Johansson M, Pring M, Nygard M, Waterboer T. Simon J, et al. Cancer Epidemiol. 2022 Apr;77:102117. doi: 10.1016/j.canep.2022.102117. Epub 2022 Feb 1. Cancer Epidemiol. 2022. PMID: 35121404

3

Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.

Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Teng A, Pablo J, Yu KJ, Lou PJ, Wang CP, Liu Z, Chen CJ, Middeldorp J, Mulvenna J, Bethony J, Hildesheim A, Doolan DL. Coghill AE, et al. Clin Cancer Res. 2018 Mar 15;24(6):1305-1314. doi: 10.1158/1078-0432.CCR-17-1929. Epub 2018 Jan 4. Clin Cancer Res. 2018. PMID: 29301829 Free PMC article.

4

Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.

Simon J, Schroeder L, Ingarfield K, Diehl S, Werner J, Brenner N, Liu Z, Pawlita M, Pring M, Butt J, Ness A, Waterboer T. Simon J, et al. Int J Cancer. 2020 Jul 15;147(2):461-471. doi: 10.1002/ijc.33006. Epub 2020 Apr 24. Int J Cancer. 2020. PMID: 32279316 Free article.

5

Combining Epstein-Barr virus antibodies for early detection of nasopharyngeal carcinoma: A meta-analysis.

Lian M. Lian M. Auris Nasus Larynx. 2023 Jun;50(3):430-439. doi: 10.1016/j.anl.2022.09.010. Epub 2022 Oct 12. Auris Nasus Larynx. 2023. PMID: 36241564

6

Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.

Chen H, Chi P, Wang W, Li L, Luo Y, Fu J, Zhang L, Liu W. Chen H, et al. Int J Infect Dis. 2014 Aug;25:110-5. doi: 10.1016/j.ijid.2014.03.1373. Epub 2014 May 27. Int J Infect Dis. 2014. PMID: 24878579 Free article.

7

Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma.

Paudel S, Warner BE, Wang R, Adams-Haduch J, Reznik AS, Dou J, Huang Y, Gao YT, Koh WP, Bäckerholm A, Yuan JM, Shair KHY. Paudel S, et al. Clin Cancer Res. 2022 Dec 1;28(23):5221-5230. doi: 10.1158/1078-0432.CCR-22-1600. Clin Cancer Res. 2022. PMID: 36165913 Free PMC article.

8

Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.

Paramita DK, Fachiroh J, Haryana SM, Middeldorp JM. Paramita DK, et al. J Clin Virol. 2008 Aug;42(4):343-52. doi: 10.1016/j.jcv.2008.03.006. Epub 2008 May 1. J Clin Virol. 2008. PMID: 18455473

9

A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma.

Liu W, Li H, Sheng H, Liu X, Chi P, Wang X, Mao M. Liu W, et al. Adv Ther. 2020 Oct;37(10):4280-4290. doi: 10.1007/s12325-020-01461-4. Epub 2020 Aug 11. Adv Ther. 2020. PMID: 32780356 Clinical Trial.

10

Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.

Liu Y, Huang Q, Liu W, Liu Q, Jia W, Chang E, Chen F, Liu Z, Guo X, Mo H, Chen J, Rao D, Ye W, Cao S, Hong M. Liu Y, et al. Int J Cancer. 2012 Jul 15;131(2):406-16. doi: 10.1002/ijc.26380. Epub 2011 Nov 19. Int J Cancer. 2012. PMID: 21866545 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

115 results

Results by year